Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab MRI Impact in RA
NCT00425932Phase 2Completed
- Start
- Feb 2007
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in rheumatoid arthritis (RA). Started Feb 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00425932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425932.